EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2027


MARKET OUTLOOK
A Triton Market Research report states that the injectable drug delivery market in Europe is progressing at a CAGR of 7.50% during the forecast period 2019-2027.
The United Kingdom, France, Italy, Russia, Germany, Spain and the Rest of Europe comprise the injectable drug delivery market in Europe.
The increase in the elderly age group population and the growing prevalence of chronic diseases will proliferate the market of injectable delivery drug technology in Europe.
The growth of the injectable drug delivery system market in France can be owed to the increasing number of pharmaceutical companies that are engaged in the development of drug delivery technologies. The vigorous R&D activities is another important factor driving the market. As per the European Federation of Pharmaceutical Industries and Association, about 30 pharmaceutical organizations are indulged in the advancement of drug delivery technologies in France. These companies are making huge investments in developing enhanced and better quality drug administration technologies. The increasing demand for the generics on these pharmaceutical companies is expected to boost the market growth in the country.
Due to the increasing smoking habit among Italian women, lung cancer is very prevalent in the female population of the country. Besides, a high number of cases of tumors in the pancreas and thyroid are also observed. These factors, along with the growing pharmaceutical sector, are expected to intigate the market growth of injectable drug delivery systems in Italy. 
COMPETITIVE OUTLOOK
Some of the players operating in the injectable drug delivery market are Terumo Corporation, Teva Pharmaceutical Industries Ltd, Elcam Medical, Eli Lilly and Company, SANOFI, SCHOTT AG and Ericsson.
TABLE OF CONTENT 
1. EUROPE INJECTABLE DRUG DELIVERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONS
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANT
2.2.2. THREAT OF SUBSTITUTE
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. INTENSITY OF COMPETITIVE RIVALRY
2.3. MARKET SHARE OUTLOOK
2.4. KEY INSIGHT
2.5. KEY BUYING CRITERIA
2.6. LEGAL REQUIREMENT
2.7. REGULATORY FRAMEWORK
2.8. MARKET ATTRACTIVENESS INDEX
2.9. MARKET DRIVERS
2.9.1. INCREASING GERIATRIC POPULATION
2.9.2. TECHNOLOGICAL ADVANCEMENT
2.9.3. GROWING OCCURRENCE OF AUTOIMMUNE DISEASES
2.10. MARKET RESTRAINT
2.10.1. HIGH MANUFACTURING COST OF THE INJECTABLE DRUG DELIVERY
2.11. MARKET OPPORTUNITY
2.11.1. DEVELOPMENT OF BETTER INJECTABLE SYSTEMS
2.12. MARKET CHALLENGES
2.12.1. DEVELOPMENTS IN THE ALTERNATE DRUG DELIVERY SYSTEM
2.12.2. STRINGENT REGULATIONS
3. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE
3.1. PEN INJECTOR
3.2. AUTO?INJECTOR
3.3. NEEDLE-FREE INJECTOR
3.4. PREFILLED SYRINGE
4. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. SUBCUTANEOUS
4.2. INTRAMUSCULAR
4.3. INTRAVENOUS (IV)
4.4. OTHER ROUTE OF ADMINISTRATION
5. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER
5.1. CLINICS/ PHYSICIAN OFFICES
5.2. AMBULATORY CARE
5.3. HOSPITAL
5.4. HOME BASED
5.5. OTHERS END-USER
6. INJECTABLE DRUG DELIVERY MARKET – EUROPE
6.1. COUNTRY ANALYSIS
6.1.1. THE UNITED KINGDOM
6.1.2. GERMANY
6.1.3. FRANCE
6.1.4. ITALY
6.1.5. SPAIN
6.1.6. RUSSIA
6.1.7. REST OF EUROPE
7. COMPANY PROFILES
7.1. BAXTER 
7.2. BECTON, DICKINSON AND COMPANY (BD)
7.3. ELCAM MEDICAL
7.4. ELI LILLY AND COMPANY
7.5. GERRESHEIMER 
7.6. INJEX 
7.7. NOVARTIS AG
7.8. NOVO NORDISK A/S
7.9. PFIZER INC
7.10. SANOFI
7.11. SCHOTT AG
7.12. TERUMO CORPORATION
7.13. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.14. WEST PHARMACEUTICAL SERVICES INC
7.15. YPSOMED
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
 
 
LIST OF TABLES 
TABLE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
TABLE 2 EUROPE INJECTABLE DRUG DELIVERY MARKET BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS 
TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS 
TABLE 5 LYOPHILIZED DRUGS USED IN PREFILLED SYRINGE 
TABLE 6 EUROPE INJECTABLE DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 7 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 8 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)  

LIST OF FIGURES 
FIGURE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) 
FIGURE 3 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 4 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 5 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 6 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) 
FIGURE 7 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) 
FIGURE 8 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) 
FIGURE 9 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION)  
FIGURE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
FIGURE 11 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION) 
FIGURE 12 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) 
FIGURE 13 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) 
FIGURE 14 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) 
FIGURE 15 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) 
FIGURE 16 THE UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 17 GERMANY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 18 FRANCE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 19 ITALY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 20 SPAIN INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 21 RUSSIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 22 REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES TABLE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) TABLE 2 EUROPE INJECTABLE DRUG DELIVERY MARKET BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS TABLE 5 LYOPHILIZED DRUGS USED IN PREFILLED SYRINGE TABLE 6 EUROPE INJECTABLE DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 7 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 8 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) LIST OF FIGURES FIGURE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) FIGURE 3 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) FIGURE 4 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) FIGURE 5 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) FIGURE 6 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) FIGURE 7 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) FIGURE 8 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) FIGURE 9 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION) FIGURE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) FIGURE 11 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION) FIGURE 12 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) FIGURE 13 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) FIGURE 14 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) FIGURE 15 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) FIGURE 16 THE UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 17 GERMANY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 18 FRANCE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 19 ITALY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 20 SPAIN INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 21 RUSSIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 22 REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by Triton Market Research

GLOBAL RECYCLED GLASS MARKET 2020-2028

MARKET OUTLOOK According to Triton, the global recycled glass market is expected to display a positive market trend over the forecast years 2020-2028, exhibiting a CAGR of 6.02% (by revenue) and 6.25% (by volume). Glass has several advantageous prope...

GLOBAL PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per an analysis by the Triton Market Research on the global PP nonwoven market, it is estimated that the industry would show growth at a CAGR of 7.05% in the period 2020-2028. PP nonwoven material is used in the production of diaper...

NORTH AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report on the North American PP nonwoven market depicts that the market is likely to show growth at a CAGR of 6.87% in the forecast period between 2020 and 2028. The United States and Canada comprises the North...

MIDDLE EAST AND AFRICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per a Triton Market Research report, the PP nonwoven market in the Middle East and Africa is set to accelerate at a CAGR of 8.51% during the forecast period 2020-2028. Saudi Arabia, Turkey, the United Arab Emirates and the Rest of t...

LATIN AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report illustrates that the Latin American PP nonwoven market would exhibit a CAGR of 7.28% during the estimated period 2020-2028. Brazil, Mexico and the Rest of Latin America together form the PP nonwoven mark...

Publisher: Triton Market Research